Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
A business making money today isn’t necessarily a winner, which is why we analyze companies across multiple dimensions at StockStory. That said, here are two profitable companies that leverage their financial strength to beat the competition and one best left off your watchlist.
One Stock to Sell:
NESR (NESR)
Trailing 12-Month GAAP Operating Margin: 7.4%
Operating across 16 countries from Algeria to Indonesia, NESR (NASDAQ: NESR) provides oilfield services like hydraulic fracturing, cementing, and drilling to oil and gas companies.
Why Does NESR Fall Short?
- Annual revenue growth of 9.7% over the last five years was below our standards for the energy upstream and integrated energy sector
- Gross margin of 12.9% is below its competitors, leaving less money to invest in exploration and production
- Day-to-day expenses have swelled relative to revenue over the last five years as its EBITDA margin fell by 24 percentage points
NESR’s stock price of $24.12 implies a valuation ratio of 15.3x forward P/E. Read our free research report to see why you should think twice about including NESR in your portfolio.
Two Stocks to Buy:
Hims & Hers Health (HIMS)
Trailing 12-Month GAAP Operating Margin: 4.5%
Originally launched with a focus on stigmatized conditions like hair loss and sexual health, Hims & Hers Health (NYSE: HIMS) operates a consumer-focused telehealth platform that connects patients with healthcare providers for prescriptions and wellness products.
Why Should You Buy HIMS?
- Customer trends over the past two years show it’s maintaining a steady flow of new contracts that can potentially increase in value over time
- Free cash flow margin jumped by 16.9 percentage points over the last five years, giving the company more resources to pursue growth initiatives, repurchase shares, or pay dividends
- Rising returns on capital show the company is starting to reap the benefits of its past investments
At $19.58 per share, Hims & Hers Health trades at 17.4x forward P/E. Is now the time to initiate a position? See for yourself in our in-depth research report, it’s free.
LendingClub (LC)
Trailing 12-Month GAAP Operating Margin: 17.7%
Pioneering peer-to-peer lending in the US before evolving into a digital bank, LendingClub (NYSE: LC) operates a marketplace that connects borrowers with lenders, offering personal loans, auto refinancing, and banking services.
Why Is LC a Good Business?
- Market share has increased this cycle as its 25.7% annual revenue growth over the last five years was exceptional
- Additional sales over the last two years increased its profitability as the 79.1% annual growth in its earnings per share outpaced its revenue
LendingClub is trading at $15.08 per share, or 8.8x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.
Stocks We Like Even More
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.
